Workflow
天弘国证2000指数增强A
icon
Search documents
权益因子观察周报第125期:上周估值因子表现较好,本年中证2000指数增强策略超额收益为23.32%-20251014
上周估值因子表现较好,本年中证 2000 指数增强策略超额收益为 23.32% ——权益因子观察周报第 125 期 本报告导读: 大类因子表现上,上周沪深 300 内超额收益较好的是估值、市值、价量。中证 500 内较好的是估值、分析师、高频分钟。中证 1000 内较好的是估值、市值、高频分钟。 中证 2000 内较好的是估值、高频分钟、公司治理。中证全指内较好的是估值、高频 分钟、价量。沪深 300 增强上周超额 0.6%;本年超额 5.48%。中证 500 增强上周超 额 0.5%;本年超额 1.35%。中证 1000 增强上周超额 1.8%;本年超额 12.56%。中 证 2000 增强上周超额 1.39%;本年超额 23.32%。 投资要点: 风险提示:量化模型基于历史数据构建,而历史规律存在失效风险。 金融工程 /[Table_Date] 2025.10.14 | [Table_Authors] | 郑雅斌(分析师) | | --- | --- | | | 021-23219395 | | | zhengyabin@gtht.com | | 登记编号 | S0880525040105 | | | 张 ...
轻松跑赢指数!最强指增基金名单来了!易方达张胜记、鹏华苏俊杰等夺冠!
私募排排网· 2025-10-13 03:37
以下文章来源于公募排排网 ,作者观在看 公募排排网 . 看财经、查排名、买基金,就上公募排排网,申购费低至0.001折。 本文首发于公众号"公募排排网"。(点击↑↑上图查看详情) 导语 公募排排网 数据显示,全市场 755只公募指数增强基金中,有593只跑赢了对应指数,2025前三季度超额收益均值为3.03%。 分指数来看,中 证2000指数作为量化指增超额的沃土,31只中证2000指增产品前三季度收益收益高达40.74%,超额收益均值高达11.11%,表现最为亮眼。 ( 点此查看公募量化指增前三季度收益概览 ) | 指数名称 | | | 前三季度涨跌(%) 公募指增产品数 今年来收益均值(%) 今年来超额均值(%) | | | --- | --- | --- | --- | --- | | 沪深300指数 | 19.94 | 158 | 19.17 | 1.77 | | 中证500指数 | 29.46 | 156 | 29.6 | 1.48 | | 中证1000指数 | 27.15 | 88 | 34.28 | 8.32 | | 中证2000指数 | 31.74 | 31 | 40.74 | 11.11 | ...
云天励飞股价跌5.02%,天弘基金旗下1只基金重仓,持有1.05万股浮亏损失4.59万元
Xin Lang Cai Jing· 2025-09-26 06:22
天弘国证2000指数增强A(017547)基金经理为杨超、王帅。 9月26日,云天励飞跌5.02%,截至发稿,报82.60元/股,成交12.61亿元,换手率5.70%,总市值296.39 亿元。云天励飞股价已经连续3天下跌,区间累计跌幅3.92%。 资料显示,深圳云天励飞技术股份有限公司位于广东省深圳市南山区粤海街道深圳湾科技生态园10栋B 座14-15楼、33楼,香港铜锣湾希慎道33号利园1期19楼1922室,成立日期2014年8月27日,上市日期2023 年4月4日,公司主营业务涉及人工智能算法、芯片技术,研发和销售面向应用场景的人工智能产品及解 决方案。主营业务收入构成为:消费级场景业务44.22%,行业级场景业务27.66%,企业级场景业务 27.10%,其他(补充)1.02%。 从基金十大重仓股角度 数据显示,天弘基金旗下1只基金重仓云天励飞。天弘国证2000指数增强A(017547)二季度持有股数 1.05万股,占基金净值比例为0.79%,位居第六大重仓股。根据测算,今日浮亏损失约4.59万元。连续3 天下跌期间浮亏损失3.73万元。 天弘国证2000指数增强A(017547)成立日期2023年3 ...
赛微电子股价涨5.07%,天弘基金旗下1只基金重仓,持有2.99万股浮盈赚取3.77万元
Xin Lang Cai Jing· 2025-09-03 06:51
Group 1 - The core viewpoint of the news is that Saiwei Electronics has seen a significant increase in its stock price, with a rise of 5.07% to 26.11 yuan per share, and a trading volume of 2.189 billion yuan, indicating strong market interest [1] - Saiwei Electronics, established on May 15, 2008, and listed on May 14, 2015, specializes in MEMS process development, wafer manufacturing, GaN epitaxial material growth, and chip design [1] - The revenue composition of Saiwei Electronics is as follows: 54.46% from MEMS wafer manufacturing, 28.39% from MEMS process development, 11.33% from semiconductor equipment, and 5.83% from other sources [1] Group 2 - Tianhong Fund has a significant holding in Saiwei Electronics, with the Tianhong Guozheng 2000 Index Enhanced A fund holding 29,900 shares, accounting for 0.78% of the fund's net value, making it the seventh-largest holding [2] - The Tianhong Guozheng 2000 Index Enhanced A fund has achieved a year-to-date return of 42.36% and a one-year return of 86.59%, ranking 517 out of 4222 and 583 out of 3783 in its category, respectively [2] - The fund was established on March 23, 2023, with a current scale of 27.0544 million yuan [2]
机构风向标 | 梦网科技(002123)2025年二季度已披露前十大机构持股比例合计下跌1.25个百分点
Xin Lang Cai Jing· 2025-08-28 10:43
Group 1 - The core viewpoint of the news is that Mengwang Technology (002123.SZ) reported its semi-annual results for 2025, highlighting changes in institutional and public fund holdings [1] - As of August 27, 2025, a total of 7 institutional investors disclosed holdings in Mengwang Technology, with a combined shareholding of 53.5668 million shares, accounting for 6.65% of the total share capital [1] - The institutional holding ratio decreased by 1.25 percentage points compared to the previous quarter [1] Group 2 - Among public funds, three funds increased their holdings compared to the previous period, with a total increase in shareholding ratio of 0.41% [1] - One new public fund disclosed its holdings this period, while one fund did not disclose its holdings compared to the previous quarter [1] - The foreign investment perspective shows that one foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 1.11% compared to the previous quarter [2]
机构风向标 | 奥比中光(688322)2024年四季度已披露前十大机构持股比例合计下跌3.09个百分点
Xin Lang Cai Jing· 2025-04-22 01:27
Group 1 - The core viewpoint of the news is that OrbiMed (688322.SH) has reported its annual results for 2024, highlighting significant institutional investor interest and changes in shareholding patterns [1] Group 2 - As of April 21, 2025, a total of 206 institutional investors disclosed holdings in OrbiMed A-shares, with a total shareholding of 127 million shares, accounting for 31.65% of the total share capital [1] - The top ten institutional investors include Shanghai Yunxin Venture Capital Co., Ltd., Zhuhai OrbiMed Investment Partnership (Limited Partnership), and others, with their combined shareholding ratio reaching 26.51% [1] - Compared to the previous quarter, the combined shareholding ratio of the top ten institutions decreased by 3.09 percentage points [1] Group 3 - In the public fund sector, four public funds reported a decrease in holdings compared to the previous quarter, including Bank of China Securities Advantage Manufacturing Stock A and others, with a slight decline in the proportion of reduced holdings [2] - A total of 193 new public funds were disclosed this period, including several funds such as Xingquan Helun Mixed A and others [2] - One public fund, Tianhong Guozheng 2000 Index Enhanced A, was not disclosed in this period compared to the previous quarter [2]